KNX-200

N/A

Report date: 2023/02/19 22:08:15
NME

Base Information

Drug NameKNX-200
Drug Alias NameKNX-200
ClassificationSmall molecules
Mechanisms of ActionOxytocin receptor agonists
TargetsOxytocin receptor
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKinoxis Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A